ILLUMENATE Pivotal Post-Approval Study (PAS)

Completed · Not applicable

Conditions studied: Peripheral Artery Disease

In brief

The ILLUMENATE Pivotal PAS is a continued follow-up study which will include 300 subjects from forty-three (43) sites across the United States and Austria previously enrolled in the ILLUMENATE Pivotal pre-market study to evaluate the Stellarex DCB compared to the PTA control device for the treatment of de-novo or post-PTA occluded/stenotic or reoccluded/restenotic (except for in-stent) SFA and/or popliteal arteries.

Key facts

Study ID
NCT03421561
Run by
Spectranetics Corporation
People needed
300
Starts
2013-06-18
Expected to finish
2020-10-06
Last updated by the study team
2024-02-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.